The company depends on third-party suppliers for raw materials, components, parts, and consumables necessary for manufacturing product candidates used in clinical trials and research and development. Disruptions or delays from these suppliers, particularly during epidemics or pandemics, may adversely affect manufacturing, clinical development, regulatory approvals, and strategic collaborations. Government actions during global health crises could also impact supplier services and the company's rights or economic opportunities. The manufacturing of mRNA-based medicines involves complex processes requiring specialized expertise, substantial capital investment, and adherence to current Good Manufacturing Practice (cGMP) regulations. Challenges in production, scaling, and validation by the company or third-party manufacturers could result in delays or interruptions in the supply of product candidates or approved products.
Curevac N V's Comment on Supply Chain
The company depends on third-party suppliers for raw materials, components, parts, and consumables necessary for manufacturing product candidates used in clinical trials and research and development. Disruptions or delays from these suppliers, particularly during epidemics or pandemics, may adversely affect manufacturing, clinical development, regulatory approvals, and strategic collaborations. Government actions during global health crises could also impact supplier services and the company's rights or economic opportunities. The manufacturing of mRNA-based medicines involves complex processes requiring specialized expertise, substantial capital investment, and adherence to current Good Manufacturing Practice (cGMP) regulations. Challenges in production, scaling, and validation by the company or third-party manufacturers could result in delays or interruptions in the supply of product candidates or approved products.
Sources:
Curevac N v 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Curevac N v ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
